pubmed-article:15662494 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15662494 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:15662494 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:15662494 | lifeskim:mentions | umls-concept:C0007177 | lld:lifeskim |
pubmed-article:15662494 | lifeskim:mentions | umls-concept:C0205282 | lld:lifeskim |
pubmed-article:15662494 | lifeskim:mentions | umls-concept:C0522523 | lld:lifeskim |
pubmed-article:15662494 | lifeskim:mentions | umls-concept:C0449450 | lld:lifeskim |
pubmed-article:15662494 | pubmed:issue | 9 | lld:pubmed |
pubmed-article:15662494 | pubmed:dateCreated | 2005-8-10 | lld:pubmed |
pubmed-article:15662494 | pubmed:abstractText | The percutaneous treatment of pericardial effusion resulting in cardiac tamponade has undergone an evolution in recent years with the use of less invasive drainage techniques in selected cases. To determine optimal therapy modalities for oncology patients with malignant pericardial tamponade (MPT), the authors review their institutional experience with percutaneous needle puncture routes, means of imaging-guided drainage and percutaneous management of the pericardial fluid effusion (pericardial sclerosis and balloon pericardiotomy). Advantages and limits of the percutaneous techniques will be compared to the surgical treatment. | lld:pubmed |
pubmed-article:15662494 | pubmed:language | eng | lld:pubmed |
pubmed-article:15662494 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15662494 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15662494 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15662494 | pubmed:month | Sep | lld:pubmed |
pubmed-article:15662494 | pubmed:issn | 0938-7994 | lld:pubmed |
pubmed-article:15662494 | pubmed:author | pubmed-author:BrunnerPP | lld:pubmed |
pubmed-article:15662494 | pubmed:author | pubmed-author:MarcyP YPY | lld:pubmed |
pubmed-article:15662494 | pubmed:author | pubmed-author:BondiauP YPY | lld:pubmed |
pubmed-article:15662494 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15662494 | pubmed:volume | 15 | lld:pubmed |
pubmed-article:15662494 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15662494 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15662494 | pubmed:pagination | 2000-9 | lld:pubmed |
pubmed-article:15662494 | pubmed:dateRevised | 2010-12-1 | lld:pubmed |
pubmed-article:15662494 | pubmed:meshHeading | pubmed-meshheading:15662494... | lld:pubmed |
pubmed-article:15662494 | pubmed:meshHeading | pubmed-meshheading:15662494... | lld:pubmed |
pubmed-article:15662494 | pubmed:meshHeading | pubmed-meshheading:15662494... | lld:pubmed |
pubmed-article:15662494 | pubmed:meshHeading | pubmed-meshheading:15662494... | lld:pubmed |
pubmed-article:15662494 | pubmed:meshHeading | pubmed-meshheading:15662494... | lld:pubmed |
pubmed-article:15662494 | pubmed:meshHeading | pubmed-meshheading:15662494... | lld:pubmed |
pubmed-article:15662494 | pubmed:meshHeading | pubmed-meshheading:15662494... | lld:pubmed |
pubmed-article:15662494 | pubmed:meshHeading | pubmed-meshheading:15662494... | lld:pubmed |
pubmed-article:15662494 | pubmed:meshHeading | pubmed-meshheading:15662494... | lld:pubmed |
pubmed-article:15662494 | pubmed:meshHeading | pubmed-meshheading:15662494... | lld:pubmed |
pubmed-article:15662494 | pubmed:meshHeading | pubmed-meshheading:15662494... | lld:pubmed |
pubmed-article:15662494 | pubmed:meshHeading | pubmed-meshheading:15662494... | lld:pubmed |
pubmed-article:15662494 | pubmed:meshHeading | pubmed-meshheading:15662494... | lld:pubmed |
pubmed-article:15662494 | pubmed:meshHeading | pubmed-meshheading:15662494... | lld:pubmed |
pubmed-article:15662494 | pubmed:meshHeading | pubmed-meshheading:15662494... | lld:pubmed |
pubmed-article:15662494 | pubmed:year | 2005 | lld:pubmed |
pubmed-article:15662494 | pubmed:articleTitle | Percutaneous treatment in patients presenting with malignant cardiac tamponade. | lld:pubmed |
pubmed-article:15662494 | pubmed:affiliation | Interventional Radiology Department, Antoine Lacassagne Center, 33 Avenue de valombrose, 06189 Nice Cedex 2, France. pierre-yves.marcy@cal.nice.fnclcc.fr | lld:pubmed |
pubmed-article:15662494 | pubmed:publicationType | Journal Article | lld:pubmed |